4//SEC Filing
Cole Hugh M 4
Accession 0001640455-22-000019
CIK 0001640455other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:38 PM ET
Size
6.6 KB
Accession
0001640455-22-000019
Insider Transaction Report
Form 4
Cole Hugh M
Chief Business Officer
Transactions
- Award
Common Stock
2022-02-01+42,500→ 106,716 total - Award
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 totalExercise: $7.56Exp: 2032-02-01→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The option will vest quarterly in 16 equal installments following January 1, 2022.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001604646
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:38 PM ET
- Size
- 6.6 KB